Procedures for Participating in Implanet’s Combined General Meeting of May 5, 2021 at 2 pm CEST
16 April 2021 - 07:45AM
Business Wire
A webinar will be held at 6 pm CEST on April
20, 2021 following the publication of Q1 2021 revenue
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for
PEA-PME equity savings plans), a medical technology company
specializing in vertebral and knee-surgery implants, notifies its
shareholders that its Combined General Meeting will be held on May
5, 2021 at 2 pm (CEST/Paris time) behind closed doors, and will be
broadcast live via web conference.
In accordance with current rules and regulations, all the
logistical elements enabling this Meeting to go ahead have been
implemented to take into account the current public health
situation:
- Online voting is available and should be prioritized. To this
end, the Company informs its shareholders that the secure VOTACESS
voting platform will open on Friday April 16, 2021.
Procedures are detailed in the practical guide, which is also
available on the Company’s website.
If your financial intermediary (your bank) subscribes to this
VOTACCES platform, you can access it with your usual
username and password via your share management web interface.
Please note that you will no longer be able to log in to the
platform from 3 pm CEST on May 4, 2021.
In order to avoid possible congestion of the VOTACCES website
and given the importance of your vote, the Company recommends that
shareholders do not wait until the day before the General Meeting
to provide their voting instructions.
- Alternatively, you can also vote by post by sending in the
completed and signed paper voting form (subject to postal service
operations), in accordance with the terms indicated in the notice
of the Meeting published in the French official bulletin of legal
notices (‘Bulletin des Annonces Légales Obligatoire’ – BALO) on
March 31, 2021.
The participation of Implanet’s shareholders is decisive in
achieving the necessary quorum for this Meeting and voting on the
Company’s resolutions, and notably those pertaining to the
acquisition of Orthopaedic & Spine Development, which
specializes in developing, manufacturing and marketing
implants.
Shareholders can find the documents pertaining to this General
Meeting on the Company’s website as of today, April 16, 2021.
Shareholders can email the Investor Relations team at
implanet@newcap.eu with any questions regarding the voting
process.
Should the required quorum not be met, a second Meeting would be
called for May 18, 2021 at 2 pm CEST, also behind closed
doors.
A webinar will be held at 6 pm CEST on April 20, 2021
following the publication of Q1 2021 revenue
The Company would like to inform its shareholders that a webinar
will be held at 6 pm on April 20, 2021 following the
publication of its Q1 2021 revenue. During this web conference,
Chief Executive Officer Ludovic Lastennet and Chief Financial
Officer David Dieumegard will present Implanet’s strategic focuses
following the finalization of the agreement to acquire OSD. The
webinar will be held in French and will be followed by a Q&A
session.
To follow this webinar, shareholders are invited to log in via
the following link:
https://us02web.zoom.us/webinar/register/WN_xRVpxI-iRIOkUdiWTPU8iA
Upcoming financial event:
- Publication of Q1 2021 revenue on April 20, 2021 after
market
About Implanet
Founded in 2007, Implanet is a medical technology company that
manufactures high-quality implants for orthopedic surgery. Its
activity revolves around two product ranges, the latest generation
JAZZ® implant, designed to improve the treatment of spinal
pathologies requiring vertebral fusion surgery, and the MADISON
implant designed for first-line prosthetic knee surgery. Implanet’s
tried-and-tested orthopedic platform is based on product
traceability. Protected by four families of international patents,
JAZZ® and MADISON have obtained 510(k) regulatory clearance from
the Food and Drug Administration (FDA) in the United States, the CE
mark as well as the ANVISA authorization in Brazil. Implanet
employs 29 staff and recorded 2020 sales of €6.0 million. For
further information, please visit www.implanet.com. Based near
Bordeaux in France, Implanet established a US subsidiary in Boston
in 2013. Implanet is listed on Euronext™ Growth market in
Paris.
The Company would like to remind that the table for monitoring
the equity line (OCA, OCAPI, BSA) and the number of shares
outstanding, is available on its website:
http://www.implanet-invest.com/suivi-des-actions-80
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210415005675/en/
IMPLANET Ludovic Lastennet, CEO David Dieumegard, CFO
Tel.: +33 (0)5 57 99 55 55 investors@Implanet.com NewCap
Investor Relations Mathilde Bohin Nicolas Fossiez Tel.: +33 (0)1 44
71 94 94 Implanet@newcap.eu NewCap Media Relations Nicolas
Merigeau Tel.: +33 (0)1 44 71 94 94 Implanet@newcap.eu
Implanet (EU:ALIMP)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Implanet (EU:ALIMP)
Historical Stock Chart
Von Mär 2023 bis Mär 2024